Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
European Urology Oncology|July 22, 2019
Treatment Facility Volume and Survival in Patients with Advanced Prostate CancerShreyas S Joshi, Elizabeth R Handorf, Danielle Sienko, et al.
Clinical Genitourinary Cancer|December 3, 2014
A review of interventional clinical trials in renal cell carcinoma: a status report from the ClinicalTrials.gov WebSiteMatthew Zibelman, Peter Barth, Elizabeth Handorf, et al.
Investigational New Drugs|June 21, 2015
Phase I study of the mTOR inhibitor ridaforolimus and the HDAC inhibitor vorinostat in advanced renal cell carcinoma and other solid tumorsMatthew Zibelman, Yu-Ning Wong, Karthik Devarajan, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 4, 2025
Multi-institutional Analysis of Immune-Oncology Combination Therapy for Metastatic MiT Family Translocation Renal Cell CarcinomaYasser Ged, Amina Touma, Luis Meza Contreras, et al.
The Oncologist|June 28, 2017
Immune-Related Adverse Events as a Biomarker in Non-Melanoma Patients Treated with Programmed Cell Death 1 InhibitorsJulia Judd, Matthew Zibelman, Elizabeth Handorf, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 14, 2021
Venous thromboembolism in lung transplant recipients real world experience from a high volume centerMatthew Zheng, Ibraheem Yousef, Albert J Mamary, et al.
European Urology Oncology|March 3, 2023
Global Meta-analysis of Urine Microbiome: Colonization of Polycyclic Aromatic Hydrocarbon-degrading Bacteria Among Bladder Cancer PatientsLaura Bukavina, Ilaha Isali, Rashida Ginwala, et al.
Urologic Oncology|July 1, 2025
Enfortumab vedotin-related skin toxicities in patients with urothelial carcinoma: A systematic review and meta-analysisGabriela Gazzoni, Isabella Michelon, Maysa Vilbert, et al.
Prostate Cancer and Prostatic Diseases|January 26, 2022
A randomized phase 2 study of bicalutamide with or without metformin for biochemical recurrence in overweight or obese prostate cancer patients (BIMET-1)Marijo Bilusic, Nicole J Toney, Renee N Donahue, et al.
Oncotarget|September 15, 2016
TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracyPhillip N Gray, Huy Vuong, Pei Tsai, et al.
Pageof 6